A PERSPECTIVE ON ANTIINFECTIVE AGENTS INTERACTION IN HUMAN IMMUNODEFICIENCY VIRUS PATIENTS WITH MALARIAL INFECTION


Girish Mahadeorao Bhopale

Abstract


ABSTRACT
Despite recent research advances in anti-infective agents (achievements), Human immunodeficiency virus (HIV), and malaria infection are currently
considered two main global human health problems. Given the considerable geographical overlap between malaria and HIV, a substantial number of
co-infection incidences occur in human. The purpose of this review is to summarize the information on the clinical impact of co-infection, therapeutic
anti-infective agents’ interaction in human and future research priorities.
Keywords: Malaria, Human immunodeficiency virus, Co-infection, Anti-malarial drug and anti-retroviral drug interaction, Public health, Clinical
epidemiology, Anti-infective agents.


| PDF |

References


REFERENCES

Hochman S, Kim K. The impact of HIV and Malaria co-infection: What

is known and suggested venues for further study. Interdiscip Perspect

Infect Dis 2009;2009:617954.

Abu-Raddad LJ, Patnaik P, Kublin JG. Dual infection with HIV and

malaria fuels the spread of both diseases in sub-Saharan Africa. Science

;314(5805):1603-6.

Available from: http://www.who.int/malaria/areas/high_risk_groups/

hiv_aids_patients/en/. [Last accessed on 2014 Nov 24].

Nkuo-Akenji T, Tevoufouet EE, Nzang F, Fon E, Ebong IN. HIV/AIDS

and malaria in pregnant women from Cameroon short running title:

HIV, malaria in pregnancy. Afr J Health Sci 2011;18:105-9.

Bhopale GM. Emerging drugs for the treatment of human

immunodeficiency virus. Recent Pat Antiinfect Drug Discov

;7:45-52.

The global malarial epidemic. Kaiser Family Foundation Files.

Available from: http://www. worldprocess.com/2012/10/7882-04-pdf.

[Last accessed on 2014 Apr 04].

The global HIV/AIDS epidemic, Kaiser Family foundazation. Files.

Available from: http://www.wordpress.com/2013/10/3030/17-globalhiv.pdf.

[Last accessed on 2014 Apr

.

Zafar KS, Kumar A, Haque SF. HIV-Malaria: An emerging challenge

for the mankind. Int J Res Health Sci 2014;2(4):1143-9.

Kublin JG, Patnaik P, Jere CS, Miller WC, Hoffman IF, et al. Effect

of Plasmodium falciparum Malaria on concentration of HIV-1-RNA in

the blood of adults in rural Malawi: A prospective cohort study. Lancet

;365(9455):233-40.

Flateau C, Le Loup G, Pialoux G. Consequences of HIV infection

on malaria and therapeutic implications: A systematic review. Lancet

Infect Dis 2011;11(7):541-56.

Berkley JA, Bejon P, Mwangi T, Gwer S, Maitland K, Williams TN,

et al. HIV infection among children with severe malaria. Clin Infect Dis

;49(3):336-43.

Hewitt K, Steketee R, Mwapasa V, Whitworth J, French N. Interactions

between HIV and malaria in non-pregnant adults: Evidence and

implications. AIDS 2006;20(16):1993-2004.

Focà E, Odolini S, Brianese N, Carosi G. Malaria and HIV in

adults:When the parasite runs into the virus. Mediterr J Hematol Infect

Dis. 2012:4(1)e2012032.

Hoffman IF, Jere CS, Taylor TE, Munthali P, Dyer JR, Wirima JJ, et al.

The effect of Plasmodium falciparum malaria on HIV-1 RNA blood

plasma concentration. AIDS 1999;13(4):487-94.

Devenport GC, Ouma C, Hitter JB, Were T, Ouma Y, Ong’echa JM,

et al. Hematological predictors of increased severe anemia in Kanyan

children coinfected with Plasmodium falciparum and HIV-1. Am J

Hematol 2010;85(4):227-33.

Ayisi JG, van Eijk AM, Newman RD, ter Kuile FO, Shi YP, Yang C,

et al. Maternal malaria and perinatal HIV transmission, western Kenya.

Emerg Infect Dis 2004;10(4):643-52.

Fehintola FA, Akinyinka OO, Adewole IF, Maponga CC, Ma Q, Morse

FD. Drug interactions in the treatment and chemoprophylaxis of

malaria in HIV infected individuals in sub-Saharan Africa. Curr Drug

Metab 2111;12(1):51-6.

Kredo T, Mauff K, Van der Walt JS, Wiesner L, Maartens G, Cohen K,

et al. Interaction between artemether–lumefantrine and nevirapine

based antiretroviral therapy in HIV-1 infected patients. Antimicrob

Agents Chemother 2011;55(12):5616-23.

Byakika-Kibwika P, Lamorde M, Mayito J, Nabukeera L, Namakula R,

Mayanja-Kizza H, et al. Significant pharmacokinetic interactions

Asian J Pharm Clin Res, Vol 9, Issue 4, 2016, 15-17

Bhopale

between artemether/lumefantrine and efavirenz or nevirapine in HIV –

Infected Uganda adults. J Antimicrob Chemother 2012;67(9):2213-21.

Van Geertruyden JP. Interactions between malaria and human

immunodeficiency virus anno 2014. Clin Microbiol Infect

;20(4):278-85.

Achan J, Kakuru A, Ikilezi G, Ruel T, Clark TD, Nsanzabana C, et al.

Antiretroviral agents and prevention of malaria in HIV-infected

Ugandan children. N Engl J Med 2012;367(22):2110-8.

Savarino A, Lucia MB, Rastrelli E, Rutella S, Golotta C, Morra E,

et al. Anti-HIV effects of chloroquine: Inhibition of viral particle

glycosylation and synergism with protease inhibitors. J Acquir Immune

Defic Syndr 2004;35(3):223-32.

Manyando C, Njunju EM, D’ Alessandro U, van Geertruyden JP.

Safety and efficacy of co-trimoxazole for treatment and prevention

of Plasmodium falciparum malaria: A systematic review. PLoS One

;8(2):e56916.




About this article

Title

A PERSPECTIVE ON ANTIINFECTIVE AGENTS INTERACTION IN HUMAN IMMUNODEFICIENCY VIRUS PATIENTS WITH MALARIAL INFECTION

Date

01-07-2016

Additional Links

Manuscript Submission

Journal

Asian Journal of Pharmaceutical and Clinical Research
Vol 9 Issue 4 July 2016 Page: 15-17

Print ISSN

0974-2441

Online ISSN

2455-3891

Authors & Affiliations

Girish Mahadeorao Bhopale
Girish M. Bhopale Dr. D. Y. Patil Biotechnology & Bioinformatics Institute, Dr. D.Y. Patil Vidhyapeeth, Tathawade, Pune, 411033, MS, India
India


Article Tools


Email this article (Login required)
Email the author (Login required)

Refbacks

  • There are currently no refbacks.